A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
Br J Dermatol. 2017 Sep 21;:
Authors: Sigurgeirsson B, Luger T
PMID: 28940181 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Sigurgeirsson B, Luger T Tags: Br J Dermatol Source Type: research